{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:11:13Z","timestamp":1783793473308,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Predicting progression of Dupuytren disease becomes relevant in an upcoming era with progression-preventing treatment. This study aimed to determine the course of Dupuytren disease and identify factors associated with progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Two hundred fifty-eight patients with Dupuytren disease participated in this prospective cohort study, obtaining 17,645 observations in 5 years. Outcomes were disease extent (surface area) and contracture severity (total passive extension deficit). Demographics, lifestyle, health status, exposure to manual work, and genetic risk scores were gathered as potential predictors. Subject-specific, mixed-effects models were used to estimate disease course, and logistic regression with least absolute shrinkage and selection operator was used to evaluate factors associated with the presence of progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>On average, Dupuytren disease was progressive in all finger rays with regard to area [yearly increase, 0.07 cm<jats:sup>2<\/jats:sup> (95% CI, 0.02 to 0.13 cm<jats:sup>2<\/jats:sup>) to 0.25 cm<jats:sup>2<\/jats:sup> (95% CI, 0.11 to 0.39 cm<jats:sup>2<\/jats:sup>)]. Progression in total passive extension deficit was only present on the small finger side [yearly increase, 1.75 degrees (95% CI, 0.30 to 3.20 degrees) to 6.25 degrees (95% CI, 2.81 to 9.69 degrees)]. Stability or regression in area and total passive extension deficit was observed in 11 and 13 percent and 16 and 15 percent (dominant and nondominant hands), respectively. Smoking, cancer, genetic risk score, and hand injury were univariate associated with progression in area, but after multivariate variable selection, none of these associations remained. No predictors for progression in total passive extension deficit were found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Dupuytren disease is progressive, especially with respect to disease extent. Progression in contracture severity is mainly present on the small finger side of the hand. None of the traditional risk and diathesis factors were associated with progression, indicating that new hypotheses about Dupuytren disease progression might be needed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Risk, III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000009115","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T15:00:10Z","timestamp":1649689210000},"page":"1371-1378","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Disease Course of Primary Dupuytren Disease: 5-Year Results of a Prospective Cohort Study"],"prefix":"10.1097","volume":"149","author":[{"given":"Dieuwke C.","family":"Broekstra","sequence":"first","affiliation":[{"name":"From the Department of Plastic Surgery, University of Groningen, University Medical Center Groningen; and Department of Mathematics and Computer Science, Eindhoven University of Technology."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Lanting","sequence":"additional","affiliation":[{"name":"From the Department of Plastic Surgery, University of Groningen, University Medical Center Groningen; and Department of Mathematics and Computer Science, Eindhoven University of Technology."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M. N.","family":"Werker","sequence":"additional","affiliation":[{"name":"From the Department of Plastic Surgery, University of Groningen, University Medical Center Groningen; and Department of Mathematics and Computer Science, Eindhoven University of Technology."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin R.","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"From the Department of Plastic Surgery, University of Groningen, University Medical Center Groningen; and Department of Mathematics and Computer Science, Eindhoven University of Technology."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.prs.0000438455.37604.0f","article-title":"A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of western countries.","volume":"133","author":"Lanting","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"367e","DOI":"10.1097\/PRS.0000000000004120","article-title":"A systematic review and meta-analysis on the strength and consistency of the associations between Dupuytren disease and diabetes mellitus, liver disease, and epilepsy.","volume":"141","author":"Broekstra","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R4-20250501","first-page":"367e","article-title":"Dupuytren\u2019s disease predicts increased all-cause and cancer-specific mortality: Analysis of a large cohort from the UK Clinical Practice Research Datalink.","volume":"141","author":"Kuo","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R5-20250501","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jclinepi.2004.05.007","article-title":"A cohort study linked increased mortality in patients treated surgically for Dupuytren\u2019s contracture.","volume":"58","author":"Wilbrand","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1054\/JHSB.1999.0229","article-title":"Increased mortality in Dupuytren\u2019s disease.","volume":"24","author":"Mikkelsen","year":"1999","journal-title":"J Hand Surg Br"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0895-4356(01)00413-9","article-title":"Increased total mortality and cancer mortality in men with Dupuytren\u2019s disease: A 15-year follow-up study.","volume":"55","author":"Gudmundsson","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: Paradigms for connective tissue remodeling.","volume":"180","author":"Hinz","year":"2012","journal-title":"Am J Pathol"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/J.JHSB.2005.07.002","article-title":"Dupuytren\u2019s contracture: An update of biomolecular aspects and therapeutic perspectives.","volume":"30","author":"Cordova","year":"2005","journal-title":"J Hand Surg Br"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target.","volume":"110","author":"Verjee","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2106\/00004623-197658030-00016","article-title":"Treatment of Dupuytren\u2019s contracture. Long-term results after fasciotomy and fascial excision.","volume":"58","author":"Rodrigo","year":"1976","journal-title":"J Bone Joint Surg Am"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/030097401750065292","article-title":"Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren\u2019s disease.","volume":"30","author":"Gudmundsson","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhsa.2005.03.005","article-title":"A retrospective review of the management of Dupuytren\u2019s nodules.","volume":"30","author":"Reilly","year":"2005","journal-title":"J Hand Surg Am"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ebiom.2018.06.022","article-title":"Anti-tumour necrosis factor therapy for Dupuytren\u2019s disease: A randomised dose response proof of concept phase 2a clinical trial.","volume":"33","author":"Nanchahal","year":"2018","journal-title":"EBioMedicine"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PRS.0b013e3182958a33","article-title":"Prevalence of Dupuytren disease in the Netherlands.","volume":"132","author":"Lanting","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.math.2015.01.010","article-title":"Intra- and inter-observer agreement on diagnosis of Dupuytren disease, measurements of severity of contracture, and disease extent.","volume":"20","author":"Broekstra","year":"2015","journal-title":"Man Ther"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ajhg.2017.08.006","article-title":"A genome-wide association study of Dupuytren disease reveals 17 additional variants implicated in fibrosis.","volume":"101","author":"Ng","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhsa.2015.10.027","article-title":"Clusters in short-term disease course in participants with primary Dupuytren disease.","volume":"41","author":"Lanting","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R24-20250501","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jhsa.2006.09.006","article-title":"Dupuytren\u2019s diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence.","volume":"31","author":"Hindocha","year":"2006","journal-title":"J Hand Surg Am"},{"key":"R25-20250501","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/J.JHSB.2004.06.004","article-title":"An objective method to evaluate the risk of recurrence and extension of Dupuytren\u2019s disease.","volume":"29","author":"Abe","year":"2004","journal-title":"J Hand Surg Br"},{"key":"R26-20250501","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1753193409103729","article-title":"Histological staging and Dupuytren\u2019s disease recurrence or extension after surgical treatment: A retrospective study of 124 patients.","volume":"34","author":"Balaguer","year":"2009","journal-title":"J Hand Surg Eur"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000009115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:06:36Z","timestamp":1746140796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000009115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000009115","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,11]]}}}